Lv1
50 积分 2023-10-29 加入
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy: A Randomized Double-Blind Placebo-Controlled Clinical Trial
1年前
已完结
Unlocking the Potential of SC0062: A New Horizon in IgA Nephropathy Treatment?
1年前
已完结